Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 1—January 2015
Dispatch

Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008–2011

Hendrik WilkingComments to Author , Volker Fingerle, Christiane Klier, Michael Thamm, and Klaus Stark
Author affiliations: Robert Koch-Institut, Berlin, Germany (H. Wilking, M. Thamm,. K. Stark); German National Reference Centre for Borrelia, Oberschleißheim, Germany (V. Fingerle, C. Klier)

Main Article

Figure 2

Estimated seroprevalence of Borrelia burgdorferi sensu lato IgG among the male and female population, Germany, 2008–2011. For comparison, results of Dehnert et al. (9), a previous study among children/adolescents <18 years of age, were added to the graph.

Figure 2. Estimated seroprevalence of Borrelia burgdorferi sensu lato IgG among the male and female population, Germany, 2008–2011. For comparison, results of Dehnert et al. (9), a previous study among children/adolescents <18 years of age, were added to the graph.

Main Article

References
  1. Fingerle  V, Schulte-Spechtel  UC, Ruzic-Sabljic  E, Leonhard  S, Hofmann  H, Weber  K, Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol. 2008;298:279–90. DOIPubMedGoogle Scholar
  2. Strle  F, Stanek  G. Clinical manifestations and diagnosis of Lyme borreliosis. Curr Probl Dermatol. 2009;37:51–110.PubMedGoogle Scholar
  3. Rizzoli  A, Hauffe  H, Carpi  G, Vourc  HG, Neteler  M, Rosa  R. Lyme borreliosis in Europe. Euro Surveill. 2011;16:19906 .PubMedGoogle Scholar
  4. Bacon  RM, Kugeler  KJ, Mead  PS. Surveillance for Lyme disease—United States, 1992–2006. MMWR Surveill Summ. 2008;57:1–9.PubMedGoogle Scholar
  5. Berglund  J, Eitrem  R, Ornstein  K, Lindberg  A, Ringer  A, Elmrud  H, An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med. 1995;333:1319–24. DOIPubMedGoogle Scholar
  6. Huppertz  HI, Böhme  M, Standaert  SM, Karch  H, Plotkin  SA. Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis. 1999;18:697–703. DOIPubMedGoogle Scholar
  7. Wilking  H, Stark  K. Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009–2012. Ticks Tick Borne Dis. 2014;5:219–24.
  8. Ertel  SH, Nelson  RS, Cartter  ML. Effect of surveillance method on reported characteristics of Lyme disease, Connecticut, 1996–2007. Emerg Infect Dis. 2012;18:242–7. DOIPubMedGoogle Scholar
  9. Dehnert  M, Fingerle  V, Klier  C, Talaska  T, Schlaud  M, Krause  G, Seropositivity of Lyme borreliosis and associated risk factors: a population-based study in children and adolescents in Germany (KiGGS). PLoS ONE. 2012;7:e41321. DOIPubMedGoogle Scholar
  10. Scheidt-Nave  C, Kamtsiuris  P, Gosswald  A, Holling  H, Lange  M, Busch  MA, German health interview and examination survey for adults (DEGS)—design, objectives and implementation of the first data collection wave. BMC Public Health. 2012;12:730. DOIPubMedGoogle Scholar
  11. Tomao  P, Ciceroni  L, D'Ovidio  MC, De  RM, Vonesch  N, Iavicoli  S, Prevalence and incidence of antibodies to Borrelia burgdorferi and to tick-borne encephalitis virus in agricultural and forestry workers from Tuscany, Italy. Eur J Clin Microbiol Infect Dis. 2005;24:457–63. DOIPubMedGoogle Scholar
  12. Hristea  A, Hristescu  S, Ciufecu  C, Vasile  A. Seroprevalence of Borrelia burgdorferi in Romania. Eur J Epidemiol. 2001;17:891–6. DOIPubMedGoogle Scholar
  13. Hassler  D, Zoller  L, Haude  M, Hufnagel  HD, Sonntag  HG. Lyme borreliosis in an endemic region in Europe: prevalence of antibodies and clinical spectrum [in German]. Dtsch Med Wochenschr. 1992;117:767–74 . DOIPubMedGoogle Scholar
  14. Carlsson  SA, Granlund  H, Nyman  D, Wahlberg  P. IgG seroprevalence of Lyme borreliosis in the population of the Aland Islands in Finland. Scand J Infect Dis. 1998;30:501–3 and. DOIPubMedGoogle Scholar
  15. Nadelman  RB, Hanincova  K, Mukherjee  P, Liveris  D, Nowakowski  J, McKenna  D, Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med. 2012;367:1883–90 . DOIPubMedGoogle Scholar

Main Article

Page created: December 19, 2014
Page updated: December 19, 2014
Page reviewed: December 19, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external